Hints and tips:
...One thing to start: Credit Suisse investors have warned that they will try to block any move to extend the tenure of the bank’s longtime vice-chair Severin Schwan, as the scandal-hit bank faces growing pressure...
...Weill expert James Holmes conducts....
...Séverin Brizay is leaving Bank of America just 18 months after joining the bank in London....
...“Spark Therapeutics’ proven expertise in the entire gene therapy value chain may offer important new opportunities for the treatment of serious diseases,” said Severin Schwan, Roche’s chief executive....
...Severin Brizay, UBS’s head of M&A for Europe, the Middle East and Africa, and Laurent Dhome, a managing director covering financial sponsors in Europe, will join BofA in August, Bloomberg reported and confirmed...
...But our guides, Francis Kelsey and Severin Marchand, had to find it first. Looking upwards, they pointed to a mountainside that two days earlier had been knee-deep in the stuff....
...Intrepid documentarian Severin Unck has travelled with her film crew to waterworld Venus to investigate the mysterious disappearance of a colony....
...Severin Brizay, head of M&A for Europe, Middle East and Africa at UBS, says: “Five years ago, Europe was scaring everyone and now that is gone....
...Severin Schwan, Roche’s chief executive, said the group had experienced a “good” first half, drawing attention to the progress of two of Roche’s breast cancer medicines, Perjeta and Kadcyla....
...We have had positive news from our product pipeline, including study results for Perjeta in breast cancer and a new combination therapy with Zelboraf in melanoma,” said Severin Schwan, chief executive....
...Severin Schwan, chief executive of Roche, admits there will be “tough negotiations” ahead. “It’s a market-driven system....
...Severin Schwan, chief executive, described the results as “solid”....
...Severin Schwan, Roche chief executive, has insisted the group will remain a disciplined dealmaker and has shown little enthusiasm for the renewed round of multibillion-dollar deals that have roiled the pharmaceuticals...
...Like Severin Schwan, his counterpart at local rival Roche, Mr Jimenez’s background is not in pharma....
...Subject to shareholder approval, they will be replaced by Roche’s CEO Severin Schwan, and Sebastian Thrun, a scientist and founder of the online university, Udacity....
...Severin Schwan told the Financial Times in an interview: “If the right opportunity comes up, we would be extremely open to talk with Novartis as we would be with all the other players.”...
...Severin Schwan, chief executive, said that 2013 had been “a very good year” for Roche and that the group’s “strong” pipeline of new drugs left it well positioned for the future....
...Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and “one-dimensional” approach of governments fixated on their debt problems, says Severin...
...Where: The subterranean lair of a James Bond villain. Roger Moore is waiting just offset to reclaim his car keys....
...However, Severin Schwan said there was no “systemic risk” with regard to compliance in China, and reiterated that Roche had not been contacted by Chinese authorities in relation to anti-corruption investigations...
...According to Travail Suisse, an umbrella organisation for trade unions which tracks executive pay, the highest multiple in 2012 was at Roche, whose chief executive, Severin Schwan, earned 261 times the wage...
...some of Roche’s key drugs are likely to face tougher generic competition over the next few years, and coping with this adjustment will be one of the big challenges for Mr Franz and Roche’s chief executive Severin...
...Analysts at Citi described the trading update as “positive”, while Severin Schwan, Roche’s chief executive, said the group had begun the year well, adding that the launch of two new cancer drugs – Kadcyla...
...Severin Schwan, chief executive of the Swiss pharmaceuticals giant, said that he expected the patterns and growth rates of 2012 – during which US sales were up 7 per cent, while those in Europe were down...
...Severin Schwan, chief executive, acknowledged the “current pressure” in the market, but stressed that diabetes remained an important area for Roche....
International Edition